DGX
Quest Diagnostics Incorporated
233.10$
+0.5%
vs. previous close
Closing price · As of: Sep 30, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +154.6% | -70.8% | +133.8% | -1.1% | +30.3% | -32.3% | +73.2% | +3.5% | -17.4% | -40.2% | +68.3% | – | |
| – | -1.8% | +6.4% | +0.9% | +6.8% | +8.0% | +3.7% | +2.1% | -0.7% | +2.1% | +1.4% | -0.7% | – | |
| – | +5.6% | +15.8% | -9.1% | -5.0% | +42.1% | -18.5% | -4.5% | -4.8% | +25.0% | -20.0% | +15.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -206.9% | – | – | – | -792.3% | – | -36.4% | +82.9% | -428.1% | – | – | |
| – | -31.4% | +44.4% | -11.5% | +15.2% | +16.0% | -4.9% | -7.7% | +33.3% | +9.7% | -27.8% | +21.1% | – | |
| – | -88.0% | +86.8% | -6.1% | +716.5% | -69.3% | -77.1% | +7.8% | +62.1% | -5.0% | -20.4% | -11.8% | – | |
| – | +0.0% | -1.2% | +6.3% | +0.0% | +0.0% | +0.0% | +7.1% | -1.1% | +1.1% | -2.2% | +9.1% | – | |
| – | -558.3% | -91.6% | – | – | +15,000.0% | – | +44.8% | -457.1% | +100.0% | – | – | – | |
| – | – | – | – | – | -100.1% | +38,400.0% | -43.9% | -100.0% | – | +0.0% | +500.0% | – | |
| – | – | -217.7% | +137.3% | – | -109.6% | +230.0% | -47.8% | -15.7% | +16.2% | -47.0% | +160.5% | – | |
| – | +3,094.1% | -139.0% | – | – | -143.6% | – | – | -13.7% | -110.6% | – | – | – | |
| – | +346.1% | -89.0% | +436.0% | -6.7% | +36.4% | -42.2% | +121.3% | -3.9% | -26.7% | -46.6% | +101.2% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.